Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-01 Sale |
2024-10-02 4:11 pm |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
15,000 | $48.45 | $726,730 | 113,810 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-02 4:25 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
18,402 | $58.68 | $1,079,816 | 50,743 (Indirect Direct) |
View |
| 2024-05-01 Sale |
2024-05-02 4:58 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $52.69 | $526,913 | 69,145 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-02 4:18 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
20,000 | $49.9 | $997,946 | 22,093 (Indirect Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 4:05 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $56.37 | $563,726 | 98,898 (Indirect Direct) |
View |
| 2024-02-05 Sale |
2024-02-07 5:18 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
25,000 | $47.31 | $1,182,660 | 265,608 (Indirect Direct) |
View |
| 2024-01-26 Sale |
2024-01-29 5:36 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
31,772 | $47.11 | $1,496,706 | 76,362 (Indirect Direct) |
View |
| 2024-01-02 Sale |
2024-01-03 4:11 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $39.24 | $392,409 | 97,498 (Indirect Direct) |
View |
| 2023-12-15 Sale |
2023-12-18 7:09 pm |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
40,000 | $39.33 | $1,573,310 | 107,498 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-14 Exercise |
2025-04-15 8:57 pm |
2020-10-27 2026-10-26 |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
7,792 | $0 | 38,354 (Direct) |
View |
| 2025-04-14 Exercise |
2025-04-15 8:57 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
7,792 | $4.3386 | 38,354 (Direct) |
View |
| 2025-02-27 Option Award |
2025-02-27 8:04 pm |
N/A 2035-02-26 |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-02 4:11 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
15,000 | $16 | 113,810 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-02 4:11 pm |
N/A 2031-07-29 |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
15,000 | $0 | 113,810 (Direct) |
View |
| 2024-08-31 Option Award |
2024-09-04 9:51 pm |
N/A 2034-08-30 |
AEON Biopharma Inc. | AEON | Thunen Shelley B Director |
132,231 | $0 | 132,231 (Direct) |
View |
| 2024-08-07 Option Award |
2024-08-08 4:12 pm |
N/A 2034-08-06 |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-07-15 Exercise |
2024-07-16 8:15 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
16,505 | $4.34 | 38,235 (Direct) |
View |
| 2024-07-15 Exercise |
2024-07-16 8:15 pm |
2020-10-27 2026-10-26 |
RxSight Inc. | RXST | Thunen Shelley B See remarks |
16,505 | $0 | 38,235 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-02 4:25 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $15.6 | 50,743 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-02 4:25 pm |
N/A 2031-03-22 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $0 | 50,743 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-02 4:58 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,247 | $15.6 | 69,145 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-02 4:58 pm |
N/A 2031-03-22 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $0 | 69,145 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:44 pm |
N/A 2034-03-20 |
LENZ Therapeutics Inc. | LENZ | Thunen Shelley B Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2024-03-19 Option Award |
2024-03-21 7:52 pm |
N/A 2034-03-18 |
AEON Biopharma Inc. | AEON | Thunen Shelley B Director |
16,260 | $0 | 16,260 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 4:25 pm |
N/A 2034-03-03 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
92,200 | $0 | 92,200 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:05 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $15.6 | 98,898 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:05 pm |
N/A 2031-03-22 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $0 | 98,898 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 5:18 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
6,900 | $4.34 | 265,608 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 5:18 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
25,000 | $14.95 | 265,608 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 5:18 pm |
2020-10-27 2026-10-26 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
31,900 | $0 | 265,608 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-29 5:36 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
31,772 | $15.08 | 76,362 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-29 5:36 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
4,500 | $4.34 | 76,362 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-29 5:36 pm |
2020-10-27 2026-10-26 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
36,272 | $0 | 76,362 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-03 4:11 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $15.6 | 97,498 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-03 4:11 pm |
N/A 2031-03-22 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
10,000 | $0 | 97,498 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-18 7:09 pm |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
20,000 | $15.6 | 107,498 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-18 7:09 pm |
N/A 2031-03-22 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
20,000 | $0 | 107,498 (Direct) |
View |
| 2023-08-14 Option Award |
2023-08-16 4:07 pm |
N/A 2033-08-13 |
AEON Biopharma Inc. | AEON | Thunen Shelley B Director |
58,851 | $0 | 58,851 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-10 4:13 pm |
N/A 2033-03-09 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-07-31 Option Award |
2021-08-02 8:28 pm |
N/A 2031-07-31 |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
98,367 | $0 | 98,367 (Direct) |
View |
Ownership |
2021-07-29 10:34 am |
N/A N/A |
RxSight Inc. | RXST | Thunen Shelley B Chief Financial Officer |
0 | $0 | 243,825 (Indirect) |
View |